Cerus Corporation (NASDAQ:CERS) on Nov. 4 announced financial results for the third quarter and nine months ended September 30, 2014. Revenue for the third quarter of 2014 was $10.4 million, relatively flat when compared to the $10.5 million reported during third quarter of 2013. Revenue for the first nine months of 2014 was $26.8 million, and represented a 12% decrease from the same period in 2013. Net loss for the third quarter of 2014 was $10.8 million, or $0.15 per diluted share, compared to a net loss of $20.5 million, or $0.29 per diluted share, for the third quarter of 2013. Net loss for the first nine months of 2014 was $18.6 million, or $0.43 per diluted share, compared to a net loss of $37.5 million, or $0.56 per share, for the same period of 2013. Cerus Corporation (NASDAQ:CERS) belongs to Healthcare sector. Its net profit margin is -67.90% and weekly performance is 2.69%. On last trading day company shares ended up $4.20. Cerus Corporation (NASDAQ:CERS) distance from 50-day simple moving average (SMA50) is 4.81%. Shares of ImmunoGen (NASDAQ:IMGN) have earned a consensus rating of “Hold” from the five analysts that are covering the stock. ImmunoGen, Inc. (NASDAQ:IMGN) shares increased 1.51% in last trading session and ended the day at $10.10. IMGN return on assets is -53.70%. ImmunoGen, Inc. (NASDAQ:IMGN) quarterly performance is -11.87%. Commonwealth Primary Care and UnitedHealthcare have launched an accountable care organization (ACO) to provide improved care coordination and enhanced health services to UnitedHealthcare plan participants in Maricopa and Pinal counties and surrounding areas. Globally, UnitedHealthcare serves 45 million people in health benefits and is one of the businesses of UnitedHealth Group (UNH), a diversified Fortune 50 health and well-being company. On 11 November, UnitedHealth Group Incorporated (NYSE:UNH) shares increased 0.99% and was closed at $95.69. UNH EPS growth in last 5 year was 18.00%. UnitedHealth Group Incorporated (NYSE:UNH) year to date (YTD) performance is 28.68%. Blue Nile, Inc. (NASDAQ:NILE) will present at the 2014 RBC Capital Markets'' Technology, Internet, Media and Telecommunications Conference in Westin Times Square, New York City, NY. The event is scheduled to begin at 3:00 PM ET on November 11, 2014. Blue Nile Inc. (NASDAQ:NILE) ended the last trading day at $36.30. Company weekly volatility is calculated as 3.61% and price to cash ratio as 13.32. Blue Nile Inc. (NASDAQ:NILE) showed a weekly performance of 0.53%. Braskem S.A. (NYSE:BAK)'s sales of thermoplastic resins (polyethylene, polypropylene and PVC) grew 5% in the third quarter of 2014 compared to same period last year to reach 939 kton, reflecting third-quarter seasonality and the stronger performance of industries related to durable goods. This performance accompanied the growth in the Brazilian market. Compared to the second quarter, when the Brazilian economy decelerated, impacted, among other things, by the fewer business days due to the World Cup, Braskem's sales advanced 7%. The Company posted net revenue of R$12 billion in the quarter, or 8% higher sequentially, which is explained by the higher sales volume and average depreciation of 2% in the Brazilian real against the U.S. dollar in the period. Braskem S.A. (NYSE:BAK) shares increased 1.04% in last trading session and ended the day at $14.57. BAK Gross Margin is 13.10% and its return on assets is 2.00%. Braskem S.A. (NYSE:BAK) quarterly performance is 11.82%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
